Novel biologically based therapies for multiple myeloma.
Munshi
Nikhil C
NC
The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Hideshima
Teru
T
Chauhan
Dharminder
D
Richardson
Paul
P
Anderson
Kenneth C
KC
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D010087:Oxides / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D011480:Protease Inhibitors; D000077237:Arsenic Trioxide